QNTM — Quantum BioPharma Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$11.58m
- CA$6.88m
- 23
- 44
- 14
- 16
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Net Income/Starting Line | -39.2 | -28.5 | -33.9 | -26.7 | -18.2 |
Depreciation | |||||
Non-Cash Items | 24.5 | 4.61 | 6.26 | 0.956 | 3.26 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.39 | 0.807 | 2.89 | -7.12 | 1.64 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -13.7 | -19.1 | -20.7 | -28.3 | -10.8 |
Capital Expenditures | -0.696 | 0 | -0.5 | -0.364 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.465 | 6.51 | 0.769 | 12.5 | -0.27 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.231 | 6.51 | 0.269 | 12.1 | -0.27 |
Financing Cash Flow Items | -0.025 | — | 0 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 4.02 | 24.2 | 38.2 | -2.07 | -3.13 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -9.95 | 11.6 | 17.7 | -18.3 | -14.2 |